XML 69 R7.htm IDEA: XBRL DOCUMENT v3.20.1
CONSOLIDATED STATEMENTS OF CASH FLOWS
$ in Thousands
12 Months Ended
Jan. 31, 2020
USD ($)
Jan. 31, 2019
USD ($)
Jan. 31, 2018
USD ($)
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net income $ 11,644 $ 37,510 $ 44,912
Depreciation 23,007 24,828 21,462
Amortization of operating lease right-of-use assets 6,304    
Stock based compensation expense 397 669 1,641
Income from equity method investments (1,392) (1,536) (3,232)
Dividends received from equity method investments 1,003 4,010 6,516
Interest income from investments (73) (1,077)  
Loss on sale of investment     13
Loss on disposal of real estate and property and equipment   104 192
Deferred income tax (11,070) (23,364) (18,605)
Accounts receivable (1,591) 1,535 (1,089)
Inventory (17,157) 2,278 (3,649)
Prepaid expenses and other assets (752) 5,217 (1,170)
Income taxes refundable 1,666 (1,083) (5,542)
Accounts payable-trade 11,400 339 (1,705)
Accrued expenses and other liabilities (13,043) (1,499) 1,225
Net cash provided by operating activities 10,343 47,931 40,969
CASH FLOWS FROM INVESTING ACTIVITIES:      
Capital expenditures (3,776) (10,775) (24,017)
Purchase of short-term investment (26,025) (125,989)  
Sale of short-term investments 15,000 112,091  
Acquisition of business, net of cash acquired     (12,049)
Proceeds from sale of investment     64
Proceeds from sale of real estate and property and equipment     104
Repayment of note receivable 369 27 26
Restricted investments and deposits   5 150
Net cash used in investing activities (14,432) (24,641) (35,722)
CASH FLOWS FROM FINANCING ACTIVITIES:      
Payments to noncontrolling interests holders (4,264) (4,489) (3,529)
Capital contributions from minority investor 312 524 918
Treasury stock acquired   (21,855)  
Net cash used in financing activities (3,952) (25,820) (2,611)
NET (DECREASE) INCREASE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH (8,041) (2,530) 2,636
CASH, CASH EQUIVALENTS AND RESTRICTED CASH-Beginning of year 188,812 191,342 188,706
CASH, CASH EQUIVALENTS AND RESTRICTED CASH-End of year 180,771 188,812 191,342
Non cash financing activities-Equity awards issued 487 1,473 1,195
Non cash financing activities-Equity awards accrued 241 487 1,485
Non cash investing activities-Accrued capital expenditures 37   1,149
Initial right-of-use assets and liabilities recorded upon adoption of ASC 842 20,918    
Right-of-use assets acquired and liabilities incurred upon lease execution 432    
Cash and cash equivalents 179,658 188,531 190,988
Restricted cash 1,113 281 354
Cash, cash equivalents and restricted cash, end of period $ 180,771 $ 188,812 $ 191,342